Seller record · Telehealth service

Ivy Rx

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named; the pages say medication is prepared in a state-licensed pharmacy compliant with 503B and USP 797 standards and filled at a partner pharmacy. 1 more criterion also fails; see the table below.

At a glance

Ivy RxTelehealth service

6/8criteria passed
Price
Compounded GLP-1 injections from $77 a month, microdose from $69
Sells
compounded GLP-1 injections (semaglutide and tirzepatide), and 16 more
FDA letters
None on file
Visit Ivy RxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Miami telehealth service selling compounded GLP-1 injections at one price for every dose, a microdose GLP-1 plan, brand Mounjaro and Ozempic, sermorelin, NAD+, glutathione and B12 injections, and BPC-157 capsules sold as a supplement. The order path opens on a health questionnaire, and it names no filling pharmacy.

Operating entity Ivy Rx, PLLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSIvy Rx's personalized GLP-1 injections product page; Ivy Rx's website
S2Prescription gatingPASSIvy Rx's personalized GLP-1 injections product page; Ivy Rx's GLP-1 MD page on its app site
S3Pharmacy identificationFAILIvy Rx's personalized GLP-1 injections product page; Ivy Rx's website; Ivy Rx's terms of service page
S4Compounding disclosurePASSIvy Rx's personalized GLP-1 injections product page; Ivy Rx's safety information page
S5Analytical documentationFAILIvy Rx's personalized GLP-1 injections product page; Ivy Rx's microdose GLP-1 injections product page
S6Business addressPASSIvy Rx's contact page; Ivy Rx's privacy policy
S7Price disclosurePASSIvy Rx's personalized GLP-1 injections product page; Ivy Rx's microdose GLP-1 injections product page; Ivy Rx's Mounjaro product page; Ivy Rx's website; Ivy Rx's sermorelin injection product page; Ivy Rx's peptides page; Ivy Rx's BPC-157 product page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSPrescription products require an online evaluation by a licensed medical professional, a clinician reviews each questionnaire the same day, and the answers say its affiliated doctors are board-certified US-licensed professionals.Source: Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's website.
S2PASSThe Get Started button on the GLP-1 page opens a questionnaire whose first screen asks how many pounds the patient wants to lose, with no price or payment field, and the site lists the online questionnaire as step one before clinician review.Source: Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's GLP-1 MD page on its app site.
S3FAILNo filling pharmacy is named; the pages say medication is prepared in a state-licensed pharmacy compliant with 503B and USP 797 standards and filled at a partner pharmacy.Source: Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's website; Ivy Rx's terms of service page.
S4PASSThe GLP-1 pages describe the injections as compounded and state that the FDA does not review compounded medications for safety or effectiveness, and the safety page says compounded medications have not been FDA regulated for safety, effectiveness or quality and that FDA-approved medicines containing semaglutide and tirzepatide are available.Source: Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's safety information page.
S5FAILThe GLP-1 pages say the medication passed potency, sterility, endotoxin and pH tests in FDA and DEA registered labs, but no certificate of analysis or lot document is published.Source: Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's microdose GLP-1 injections product page.
S6PASSIvy Rx prints 111 NE 1st Street, 8th Floor #8564, Miami, FL 33132 on the contact page and as the mailing address in the privacy policy.Source: Ivy Rx's contact page; Ivy Rx's privacy policy.
S7PASSCompounded GLP-1 injections from $77 for four doses a month at the same price for every dose, and microdose GLP-1 from $69 for four doses a month. Brand Mounjaro and Ozempic at $1,399. NAD+, glutathione, MIC with B12 and B12 injections at $179. Sermorelin at $179 on its product page, $175 on the home page and $225 on the peptides page. BPC-157 capsules at $129 for 60 capsules.Source: Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's microdose GLP-1 injections product page; Ivy Rx's Mounjaro product page; Ivy Rx's website; Ivy Rx's sermorelin injection product page; Ivy Rx's peptides page; Ivy Rx's BPC-157 product page.
S8PASSNo FDA warning letter names Ivy Rx, Ivy Rx, PLLC or Ivy Health Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded GLP-1 injections (semaglutide and tirzepatide), microdose GLP-1 injections, Mounjaro, Ozempic, sermorelin injection, NAD+ injection, NAD+ nasal spray, glutathione injection, glutathione nasal spray, MIC + B12 injection, B12 injection, BPC-157 capsules, gut peptide complex, GLP-1 boost, metformin, methylene blue, anti-nausea tablets.

Visit Ivy Rx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.